Loading clinical trials...
Loading clinical trials...
To assess the safety and efficacy of PF-00299804 in patients with advanced lung cancer.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Pfizer
NCT06974734 · Carcinoma, Non Small Cell Lung, Carcinoma, Pancreatic Ductal, and more
NCT03128008 · Carcinoma, Non Small Cell Lung (NSCLC)
NCT01671332 · Carcinoma, Non Small Cell Lung
NCT00798720 · Carcinoma, Non Small Cell Lung
NCT01469000 · Carcinoma, Non Small Cell Lung
Seoul National University Hospital, Department of Internal Medicine
Seoul
Severance Hospital, Yonsei University College of Medicine, Yonsei Cancer Center
Seoul
Samsung Medical Center, Department of Medicine
Seoul
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions